Company Quick10K Filing
Resolute Oncology
10-Q 2021-03-31 Filed 2021-05-06
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-01
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-02-26
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-27
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-25
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-02-27
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-17
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
8-K 2020-11-04
8-K 2020-08-05
8-K 2020-05-13
8-K 2020-04-29
8-K 2020-02-11
8-K 2019-11-06
8-K 2019-10-01
8-K 2019-08-07
8-K 2019-05-16
8-K 2019-05-07
8-K 2019-02-07
8-K 2018-11-06
8-K 2018-08-07
8-K 2018-05-16
8-K 2018-05-08
8-K 2018-02-07

Resolute Oncology Financials

PRI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash114154136156108186112203118147149158151165193180154161152176213195212186154177280191159225262280245238
Accounts Receivable
Inventory
PP&E96113921019499112
Assets10,17010,0089,99910,0749,95110,43410,33810,43310,00510,20010,33010,38810,59410,74310,73810,72410,78110,56310,61211,01311,20511,36911,43911,67011,94512,20712,46112,49312,49712,70812,59513,07713,31813,452
Accounts Payable
Long-Term Debt375
Liabilities8,6238,4368,5768,6878,6749,0979,0629,1258,8599,0049,1089,1359,2919,4489,4939,4859,5849,4169,4669,8409,99710,14810,21810,42310,67610,92611,04211,06611,09611,26411,13411,55511,73211,844
Stockholders' Equity1,5471,5721,4231,3871,2771,3371,2751,3081,1461,1961,1731,2071,2211,2211,2461,2691,2811,4191,4271,4011,4431,4621,5211,5861,608
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue275276276287311299305308312319327324331339345345351356354363379384394405414427443460468485487495505521
Cost of Revenue
Gross Profit
R&D
SG&A
Tax2423222226252121242320232622242328262425333030233334-6017272621233029
Net Income444141424746403943433745574245434949484559585752636716866878587799796
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1880-1629951364-123897383362-196619561183569615367901794612166119136
Cash Investing221043295-72123595-4-90-4-13-10116-273332-984817-29-34-45-1-49-72-1025-82-58
Cash Financing-2-202-2-16453-98-9-167-5-5-23-28-37-88-50-79-79-28-61-48-49-45-54-67-27-63-45-75-72-85